CeriBell (NASDAQ:CBLL) Hits New 12-Month High – Here’s Why

CeriBell, Inc. (NASDAQ:CBLL) shares hit a new 52-week high on Monday . The stock traded as high as $26.75 and last traded at $21.92, with a volume of 23557 shares trading hands. The stock had previously closed at $21.30.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on CBLL shares. Cowen restated a “buy” rating on shares of CeriBell in a report on Tuesday, December 9th. TD Cowen reduced their target price on CeriBell from $36.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, November 5th. BTIG Research reissued a “buy” rating and issued a $30.00 price target on shares of CeriBell in a research note on Monday, December 15th. JPMorgan Chase & Co. dropped their price objective on shares of CeriBell from $21.00 to $17.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of CeriBell in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $24.67.

CeriBell Trading Down 1.9%

The company has a market capitalization of $775.39 million, a PE ratio of -13.87 and a beta of 1.02. The company has a debt-to-equity ratio of 0.12, a quick ratio of 12.25 and a current ratio of 12.65. The business has a fifty day moving average price of $16.99 and a 200 day moving average price of $14.92.

CeriBell (NASDAQ:CBLL) last posted its earnings results on Tuesday, November 4th. The company reported ($0.37) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.06. CeriBell had a negative net margin of 63.35% and a negative return on equity of 29.63%. The firm had revenue of $22.59 million during the quarter, compared to the consensus estimate of $21.78 million. Analysts expect that CeriBell, Inc. will post -2.46 EPS for the current fiscal year.

Insider Buying and Selling at CeriBell

In other CeriBell news, CFO Scott Blumberg sold 36,000 shares of the business’s stock in a transaction dated Monday, December 22nd. The stock was sold at an average price of $21.00, for a total transaction of $756,000.00. Following the transaction, the chief financial officer owned 118,842 shares in the company, valued at $2,495,682. The trade was a 23.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Josef Parvizi sold 25,000 shares of the stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $21.49, for a total value of $537,250.00. Following the completion of the sale, the director owned 772,652 shares of the company’s stock, valued at approximately $16,604,291.48. This trade represents a 3.13% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 252,044 shares of company stock worth $4,637,477. Corporate insiders own 20.10% of the company’s stock.

Hedge Funds Weigh In On CeriBell

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Geode Capital Management LLC boosted its position in CeriBell by 55.4% in the 2nd quarter. Geode Capital Management LLC now owns 447,936 shares of the company’s stock valued at $8,391,000 after buying an additional 159,698 shares during the last quarter. Squarepoint Ops LLC purchased a new stake in shares of CeriBell during the second quarter worth about $1,054,000. Police & Firemen s Retirement System of New Jersey lifted its stake in shares of CeriBell by 161.0% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 5,677 shares of the company’s stock worth $106,000 after acquiring an additional 3,502 shares in the last quarter. F m Investments LLC purchased a new position in CeriBell in the second quarter valued at about $381,000. Finally, TimesSquare Capital Management LLC grew its stake in CeriBell by 48.5% during the 2nd quarter. TimesSquare Capital Management LLC now owns 796,945 shares of the company’s stock valued at $14,927,000 after purchasing an additional 260,116 shares in the last quarter.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.